(Reuters) - The U.S. District Court for the District of New Jersey instead ordered Teva and Novartis not to sell or offer further generic product, beyond what has already been commercialized, until at least the completion of a status call with the court on May 29, Israel-based Teva said in a statement.
) Keywords: TEVA LOTREL/
Read more at Reuters.com Government Filings News
) Keywords: TEVA LOTREL/
Read more at Reuters.com Government Filings News
No comments:
Post a Comment